Sigma Planning Corp Has $1.55 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sigma Planning Corp trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 57.5% during the fourth quarter, HoldingsChannel reports. The fund owned 4,583 shares of the medical equipment provider’s stock after selling 6,198 shares during the period. Sigma Planning Corp’s holdings in Intuitive Surgical were worth $1,546,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. OFI Invest Asset Management acquired a new stake in shares of Intuitive Surgical during the third quarter worth $25,000. Baystate Wealth Management LLC increased its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the last quarter. Headinvest LLC acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $28,000. Stone House Investment Management LLC increased its stake in Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. Finally, Truvestments Capital LLC increased its stake in Intuitive Surgical by 137.2% in the 3rd quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 59 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the sale, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the sale, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at $9,373,093.80. The disclosure for this sale can be found here. Insiders sold 248,418 shares of company stock worth $95,927,097 over the last three months. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Mizuho lifted their price target on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Citigroup lifted their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $396.17.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG stock opened at $368.93 on Tuesday. The firm has a 50 day moving average price of $386.57 and a two-hundred day moving average price of $344.41. The company has a market capitalization of $130.77 billion, a PE ratio of 66.59, a price-to-earnings-growth ratio of 5.69 and a beta of 1.36. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the business posted $1.00 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.